Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  CanSino Biologics Inc.    6185   CNE100003F01

CANSINO BIOLOGICS INC.

(6185)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
10/21/2020 10/22/2020 10/23/2020 10/27/2020 10/28/2020 Date
190 183 170.5 165.6 153.5 Last
2430535 1253830 1911767 1050965 2275499 Volume
+5.79% -3.68% -6.83% -2.87% -7.31% Change
Financials
Sales 2020 275 M 40,9 M 40,9 M
Net income 2020 -6,87 M -1,02 M -1,02 M
Net cash position 2020 2 901 M 432 M 432 M
P/E ratio 2020 -5 005x
Yield 2020 -
Sales 2021 634 M 94,4 M 94,4 M
Net income 2021 273 M 40,6 M 40,6 M
Net cash position 2021 3 861 M 575 M 575 M
P/E ratio 2021 109x
Yield 2021 -
Capitalization 60 624 M 9 009 M 9 022 M
EV / Sales 2020 210x
EV / Sales 2021 89,5x
Nbr of Employees 429
Free-Float 37,1%
More Financials
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Notations Surperformance© of CanSino Biologics Inc.
Trading Rating : Investor Rating : -
More Ratings
All news about CANSINO BIOLOGICS INC.
10/20Mexico could share some COVID-19 vaccine liabilities with laboratories
RE
10/20Mexico could absorb some COVID-19 vaccine liabilities
RE
10/15China's Sinopharm offers experimental COVID-19 vaccines to students - WSJ
RE
10/13Mexico Signs Agreements to Buy Potential Covid-19 Vaccines
DJ
10/09China joins WHO-backed vaccine programme COVAX rejected by Trump
RE
10/08China joins WHO-backed vaccine programme COVAX rejected by Trump
RE
10/07Q&A : Where are we in the COVID-19 vaccine race?
RE
09/22Pakistan launches Phase III trials for Chinese Cansinobio's COVID-19 vaccine
RE
09/21CANSINO BIOLOGICS : Notice of the 2020 first extraordinary general meeting
PU
09/21CANSINO BIOLOGICS : Form of Proxy for use at the 2020 First Extraordinary Genera..
PU
09/21CANSINO BIOLOGICS : (1) change in use of the remaining unutilized proceeds recei..
PU
09/18CANSINO BIOLOGICS : Chinese researchers to test double doses of CanSino's corona..
RE
09/16CANSINO BIOLOGICS : Turkey begins Phase III trials of Chinese coronavirus vaccin..
RE
09/15CANSINO BIOLOGICS : In coronavirus vaccine race, China inoculates thousands befo..
RE
09/15FACTBOX : The race for a coronavirus vaccine
RE
More news
News in other languages on CANSINO BIOLOGICS INC.
10/13Mexiko sichert sich Zugang zu 146 Millionen Dosen Corona-Impfstoff
09/25CORONAVIRUS : la Chine espère produire 610 millions de doses/an de vaccins
07/20CORONAVIRUS : Des résultats prometteurs pour plusieurs essais de vaccin
07/01BioNTech treibt Corona-Impfstoffprojekt nach positiven Daten voran
05/25UBS belässt Astrazeneca auf 'Sell' - Ziel 6000 Pence
More news
Chart CANSINO BIOLOGICS INC.
Duration : Period :
CanSino Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANSINO BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 157,99 CNY
Last Close Price 133,28 CNY
Spread / Highest target 63,1%
Spread / Average Target 18,5%
Spread / Lowest Target -65,4%
EPS Revisions
Managers
NameTitle
Xue Feng Yu Chairman, Chief Executive Officer & GM
Jiang Feng Li Chairman-Supervisory Board
Shou Bai Chao COO, Executive Director & Deputy General Manager
Jing Wang Chief Financial Officer & Board Secretary
Tao Zhu Executive Director, CSO & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
CANSINO BIOLOGICS INC.160.39%9 554
CSL LIMITED5.88%94 904
WUXI BIOLOGICS (CAYMAN) INC.127.88%39 464
BIOGEN INC.-13.96%39 286
SAMSUNG BIOLOGICS CO.,LTD.46.65%37 231
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.194.00%34 838